Pfizer Tries Injecting New Life Into Its Strategy With A Generic Injectables Unit
This article was originally published in The Pink Sheet Daily
Executive Summary
Entering the sterile injectables business is one step in Pfizer's efforts to buttress its mature products by diversifying into niche markets.